Detalhe da pesquisa
1.
Immune characterization of breast cancer metastases: prognostic implications.
Breast Cancer Res
; 20(1): 62, 2018 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29929548
2.
Prospective Biomarker Analysis of the Randomized CHER-LOB Study Evaluating the Dual Anti-HER2 Treatment With Trastuzumab and Lapatinib Plus Chemotherapy as Neoadjuvant Therapy for HER2-Positive Breast Cancer.
Oncologist
; 20(9): 1001-10, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26245675
3.
Tumor size, node status, grading, HER2 and estrogen receptor status still retain a strong value in patients with operable breast cancer diagnosed in recent years.
Int J Cancer
; 132(2): E58-65, 2013 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22915138
4.
Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy.
Front Oncol
; 12: 1016295, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36531080
5.
Molecular Pathways of Breast Cancer in Systemic Sclerosis: Exploratory Immunohistochemical Analysis from the Sclero-Breast Study.
J Pers Med
; 12(12)2022 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36556228
6.
Magnetic resonance imaging and ultrasonography in predicting infiltrating residual disease after preoperative chemotherapy in stage II-III breast cancer.
Ann Surg Oncol
; 18(8): 2150-7, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21301969
7.
Application of OSNA Nomogram in Patients With Macrometastatic Sentinel Lymph Node: A Retrospective Assessment of Accuracy.
Breast Cancer (Auckl)
; 15: 11782234211014796, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33994790
8.
Clinical and Pathological Features of Breast Cancer in Systemic Sclerosis: Results from the Sclero-Breast Study.
J Pers Med
; 11(6)2021 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34203014
9.
Immune microenvironment and intrinsic subtyping in hormone receptor-positive/HER2-negative breast cancer.
NPJ Breast Cancer
; 7(1): 12, 2021 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33579951
10.
Predictive and prognostic role of p53 according to tumor phenotype in breast cancer patients treated with preoperative chemotherapy: a single-institution analysis.
Int J Biol Markers
; 25(2): 104-11, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20544688
11.
Surrogate Molecular Classification of Invasive Breast Carcinoma: A Comparison Between Core Needle Biopsy and Surgical Excision, With and Without Neoadjuvant Therapy.
Appl Immunohistochem Mol Morphol
; 28(7): 551-557, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31335485
12.
Identification of protein clusters predictive of response to chemotherapy in breast cancer patients.
J Proteome Res
; 8(11): 4916-33, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19739612
13.
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management.
Oncologist
; 13(8): 838-44, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18650259
14.
Genomic alterations at the basis of treatment resistance in metastatic breast cancer: clinical applications.
Oncotarget
; 9(60): 31606-31619, 2018 Aug 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30167082
15.
GD2 expression in breast cancer.
Oncotarget
; 8(19): 31592-31600, 2017 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28415563
16.
Polymorphous adenocarcinoma of the breast. Report of three cases.
Virchows Arch
; 448(1): 29-34, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16220292
17.
Progesterone receptor status and clinical outcome in breast cancer patients with estrogen receptor-positive locoregional recurrence.
Tumori
; 101(4): 398-403, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26045108
18.
Quantitative expression of estrogen receptor on relapse biopsy for ER-positive breast cancer: prognostic impact.
Anticancer Res
; 34(7): 3657-62, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24982383
19.
Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancer.
J Clin Oncol
; 32(10): 1050-7, 2014 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24590635
20.
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis.
J Clin Pathol
; 65(6): 503-6, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22389512